Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Nakamoto (Tokyo, Japan), Y. Sasaki (Tokyo, Japan), T. Shirai (Tokyo, Japan), K. Fujiwara (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), T. Osawa (Tokyo, Japan), M. Shimoda (Tokyo, Japan), K. Morimoto (Tokyo, Japan), Y. Tanaka (Tokyo, Japan), M. Okumura (Tokyo, Japan), T. Yoshiyama (Tokyo, Japan), H. Ogata (Tokyo, Japan), A. Kurashima (Tokyo, Japan), K. Yoshimori (Tokyo, Japan), K. Ohta (Tokyo, Japan). Predicting risk of mortality of chronic pulmonary aspergillosis. 2313

Member's Comments

No comment yet.

Related content which might interest you: Predictors of mortality in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016 Year: 2017 Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis Source: Eur Respir J, 56 (4) 2002554; 10.1183/13993003.02554-2020 Year: 2020 Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Short-term mortality in patients with acute symptomatic pulmonary embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Chronic sinusitis may be one of the risk factors developing and deteriorating primary MAC pulmonary disease in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Pulmonary and extrapulmonary morbidity and mortality in COPD Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course Year: 2012 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Increased incidence of pulmonary embolism in severe asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Morbidity and mortality in patients with chronic obstructive pulmonary disease and cachexia Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009